XBP1 and breast carcinoma: In breast cancer cells, UPR stimulation and estrogen can enhance the level of XBP1-s, which in turn promotes tumor cell proliferation by activating the transcription of NCOA3 as well as the Rab9/PIK/Akt pathway [35,36].